Actively Recruiting
SYNCED - SYNChronized Eating in Bipolar Depression Study
Led by University of Ottawa · Updated on 2026-05-01
40
Participants Needed
1
Research Sites
85 weeks
Total Duration
On this page
Sponsors
U
University of Ottawa
Lead Sponsor
O
Ottawa Hospital Research Institute
Collaborating Sponsor
AI-Summary
What this Trial Is About
Bipolar disorders (BD) are a group of complex disorders that impact mood, behaviour and cognition and are known to cause significant suffering and impairment. Circadian rhythm (your internal day/night "clock") disruption, which can involve changes in sleep-wake cycles, frequently occurs in BD. Both depression and mania are accompanied by circadian disruption. These disruptions are hypothesized to lead to mood worsening, metabolic dysfunction and inflammation. If circadian dysfunction plays a significant role in the symptoms and trajectory of BD, then treatment approaches that target these functions may lead to better outcomes. One such approach is dietary interventions. Time restricted eating (TRE) is a dietary tool that restricts the eating to an 8-12 hour window, without changing diet quality or caloric intake. Studies involving time restricted eating have been done in other conditions with promising results. There have been no studies done for mood disorders in general or bipolar disorder specifically. In this proposal, the investigators will assess two dietary interventions (TRE and nutritional counselling) to examine how TRE may represent a safe and viable adjunct to traditional treatments. The investigators aim to compare TRE with nutritional counselling, while all participants continue to receive usual care. Participants will receive support from a registered dietician and will be instructed on dietary habits. Half of participants will receive nutritional counselling and half will be asked to do TRE. Those in the TRE group will be asked to select a 10-hour window to consume all food and non-water beverages for the 8-week period. Participants will be asked to complete a screening visit to determine eligibility, and then will complete questionnaires at baseline, week 4 and week 8 examining symptoms of their illness and cognition. Participants will also provide a blood sample at baseline and week 8 for standard biochemistry tests, pregnancy testing (if applicable), and to examine inflammatory markers. Participants will also wear an actigraphy watch which provides wireless continuous monitoring of movements and ambient light. The primary outcome is feasibility and acceptability (do people agree to participate, complete the study, and follow the intervention; what do they think of the intervention). Secondary outcomes include changes in depression, anxiety, sleep, and cognition. Exploratory outcomes include inflammatory markers and circadian disruption.
CONDITIONS
Official Title
SYNCED - SYNChronized Eating in Bipolar Depression Study
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Be 18-55 years old
- Have a diagnosis of bipolar I or bipolar II disorder confirmed by QuickSCID-5
- Have depression symptoms indicated by a score of at least 12 on MADRS and 12 or less on YMRS
- Females of childbearing potential must agree to use highly effective contraception during the study
- Able to speak, read, write, and understand English or French
- Willing and able to provide informed consent
You will not qualify if you...
- Have catatonic symptoms or eating disorders as measured by QuickSCID-5
- Have unstable or inadequately treated neurological or medical conditions
- Have had prior bariatric surgery
- Taking medications that cause low blood sugar
- Are pregnant or breastfeeding
- Currently using stimulant medications
- Participating in another diet or weight management program during the trial
- Have any contraindication to fasting as judged by the clinician
- Recently began structured psychotherapy within the past 8 weeks
- Have medical conditions, substance use disorders, or suicidal thoughts that raise safety concerns for study participation
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Ottawa Hospital Research Institute
Ottawa, Ontario, Canada, K1H 8L6
Actively Recruiting
Research Team
D
Deniz Ruscuklu, BA
CONTACT
G
Gayatri Saraf, MD
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
DOUBLE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
TREATMENT
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here